Morinaga Milk Industry patented a composition using Bifidobacterium to promote FGF21 secretion, modulating palatability by reducing dietary imbalance and enhancing taste variety. GlobalData’s report on Morinaga Milk Industry gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Morinaga Milk Industry, Lactobacilli-based drug compositions was a key innovation area identified from patents. Morinaga Milk Industry's grant share as of February 2024 was 41%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11857579B2) discloses a method for modulating palatability, maintaining body temperature, and improving sensitivity to cold in a subject by administering a specific strain of Bifidobacterium bacterium, namely Bifidobacterium breve M-16V (NITE BP-02622). The method involves promoting the secretion of FGF21 in the subject to achieve the desired effects. Modulating palatability includes reducing unbalanced types of diet, promoting a wide variety of food intake without faddiness, and adjusting the sense of taste. The Bifidobacterium bacterium can be administered in food or drink compositions as well as pharmaceutical compositions to achieve the desired outcomes.
Furthermore, the patent also covers methods for maintaining body temperature and improving sensitivity to cold in a subject by administering the same strain of Bifidobacterium bacterium, Bifidobacterium breve M-16V (NITE BP-02622). These methods also rely on the promotion of FGF21 secretion in the subject to achieve the desired effects. Similar to the method for modulating palatability, the Bifidobacterium bacterium can be administered in food or drink compositions as well as pharmaceutical compositions to maintain body temperature and improve sensitivity to cold. Overall, the patent highlights the potential of using specific strains of Bifidobacterium bacterium to modulate various physiological responses in subjects, offering new possibilities for enhancing health and well-being through microbiome modulation.
To know more about GlobalData’s detailed insights on Morinaga Milk Industry, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
